127 related articles for article (PubMed ID: 29046249)
1. Humoral immunity to mumps in a highly vaccinated population in Taiwan.
Ho YH; Tsai CC; Tsai YW; Wang YC; Lin TY; Lee DJ; Chen CJ
J Microbiol Immunol Infect; 2019 Jun; 52(3):379-385. PubMed ID: 29046249
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations?
Eriksen J; Davidkin I; Kafatos G; Andrews N; Barbara C; Cohen D; Duks A; Griskevicius A; Johansen K; Bartha K; Kriz B; Mitis G; Mossong J; Nardone A; O'Flanagan D; DE Ory F; Pistol A; Theeten H; Prosenc K; Slacikova M; Pebody R
Epidemiol Infect; 2013 Mar; 141(3):651-66. PubMed ID: 22687578
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
Pang H; Zhou Y; Zhao W; Jiang Q
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30249033
[TBL] [Abstract][Full Text] [Related]
4. Mumps antibody in the Thai population 17 years after the universal measles mumps rubella vaccination program.
Ngaovithunvong V; Wanlapakorn N; Tesapirat L; Suratannon N; Poovorawan Y
J Infect Dev Ctries; 2016 Aug; 10(7):735-40. PubMed ID: 27482805
[TBL] [Abstract][Full Text] [Related]
5. [Mumps outbreak in the Plzeň Region in 2011].
Pazdiora P; Skálová J; Kubátová A; Ježová I; Morávková I; Podlesná I; Průchová J; Spáčilová M; Švecová M
Epidemiol Mikrobiol Imunol; 2015 Oct; 64(4):242-9. PubMed ID: 26795229
[TBL] [Abstract][Full Text] [Related]
6. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of anti-mumps IgG antibodies in a pediatric population].
Suárez J; Castañeda MR; Gutiérrez C; Tascón R; Rodríguez EF
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):130-4. PubMed ID: 1576184
[TBL] [Abstract][Full Text] [Related]
8. Mumps outbreak in a highly vaccinated population.
Hersh BS; Fine PE; Kent WK; Cochi SL; Kahn LH; Zell ER; Hays PL; Wood CL
J Pediatr; 1991 Aug; 119(2):187-93. PubMed ID: 1861205
[TBL] [Abstract][Full Text] [Related]
9. Sustained transmission of mumps in a highly vaccinated population: assessment of primary vaccine failure and waning vaccine-induced immunity.
Briss PA; Fehrs LJ; Parker RA; Wright PF; Sannella EC; Hutcheson RH; Schaffner W
J Infect Dis; 1994 Jan; 169(1):77-82. PubMed ID: 8277201
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of disease.
Muhsen Kh; Aboudy Y; Mendelson E; Green MS; Cohen D
Epidemiol Infect; 2008 May; 136(5):688-93. PubMed ID: 17608960
[TBL] [Abstract][Full Text] [Related]
11. Waning population immunity to measles in Taiwan.
Chen CJ; Lee PI; Hsieh YC; Chen PY; Ho YH; Chang CJ; Liu DP; Chang FY; Chiu CH; Huang YC; Lee CY; Lin TY
Vaccine; 2012 Oct; 30(47):6721-7. PubMed ID: 22634294
[TBL] [Abstract][Full Text] [Related]
12. Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy.
Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
Vaccine; 2011 Mar; 29(15):2785-90. PubMed ID: 21320550
[TBL] [Abstract][Full Text] [Related]
13. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
[TBL] [Abstract][Full Text] [Related]
14. Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy.
Smetana J; Chlibek R; Hanovcova I; Sosovickova R; Smetanova L; Polcarova P; Gal P; Dite P
Hum Vaccin Immunother; 2018 Apr; 14(4):887-893. PubMed ID: 29206078
[TBL] [Abstract][Full Text] [Related]
15. Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data.
Abrams S; Beutels P; Hens N
Am J Epidemiol; 2014 Apr; 179(8):1006-17. PubMed ID: 24573540
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of mumps before the introduction of mumps-containing vaccine in Lao PDR: results from a nationwide cross-sectional population-based survey.
Okabayashi H; Komada K; Kidokoro M; Kitamura T; Miyano S; Ito T; Phounphenghak K; Pathammavong C; Murano K; Nagai M; Mori Y; Komase K; Xeuatvongsa A; Takeda M; Hachiya M
BMC Res Notes; 2019 Mar; 12(1):155. PubMed ID: 30890154
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
19. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
20. Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay.
van den Hof S; Beaumont MT; Berbers GA; de Melker HE
Epidemiol Infect; 2003 Aug; 131(1):703-9. PubMed ID: 12948370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
